Novel benz-acyl-benzimidazole-2-derivatives
CA 1098526 A · Owner: Novartis Pharmaceuticals Canada Inc./Novartis Pharma Canada Inc. · Inventors: Habicht, Ernst; Ferrini, Pier G.; Sallmann, Alfred
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel benz-acyl-benzimidazole-2-derivatives of the formula, (I), wherein R denotes carboxy esterified carboxy, hydroxy-, methyl or hydroxymethyl etharified with a lower alkanol or a di-lower alkylamino-lower alkanol or esteriried with a lower alkane carboxylic acid or with a benzoic acid R1, denotes an aliphatic, cycloaliphatic aromatic araliphatic, furyl, thienyl, pyridyl or furyl-lower alkyl thienyl-lower, alkyl or pyridyl-lower alkyl radical R2 denotes, hydrogen or an aliphatic radical and Ph denotes a 1,2phenylene group which may, in addition to the group R1-C(= O)-, be substituted by lower alkyl, lower alkoxy hydroxyl, and/or halogen, with the proviso that R1 contains at least 2 carbon …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 31, 1981. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 31, 1998.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.